Literature DB >> 3759130

Studies in the rat of antibody-coated and N-ethylmaleimide-treated erythrocyte clearance by the spleen. II. Effects of immune complex infusion.

N Yousaf, J C Howard, B D Williams.   

Abstract

The effects of immune complex infusion on the clearance of antibody (R3/13)-coated and NEM-treated rat erythrocytes by the splenic component of the rat mononuclear phagocyte system (MPS) were investigated. Equivalence complexes of BSA-anti-BSA produced a significant delay in the clearance of the NEM cells (pre-infusion T1/2 19.7 +/- 3.9 min, post-infusion T1/2 26.5 +/- 3.8 min, mean +/- SE, n = 6, P less than 0.01), but this effect could be abolished by agents that prevented the changes in the splenic blood flow that followed complement activation. The immune complexes formed in 10-fold antigen excess (mean size 15S) did not delay the clearance of the NEM cells. Clearance of R3/13-coated cells was impaired by the infusion of immune complexes prepared at equivalence. 10-fold antigen excess or complexes prepared with F(ab')2 fragments of rabbit anti-BSA antibody. The inhibition of red cell clearance was independent of changes in blood flow, but the degree of inhibition produced did not correlate well with the dose of immune complex injected.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3759130      PMCID: PMC1453147     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  9 in total

Review 1.  Immune complex disease in experimental animals and man.

Authors:  C G Cochrane; D Koffler
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

2.  C3 split products inhibit the binding of antigen-antibody-complement complexes to B lymphocytes.

Authors:  A Eden; C Bianco; V Nussenzweig; M M Mayer
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

3.  Lack of binding of human C3, in its native state, to C3b receptors.

Authors:  M Berger; T A Gaither; C H Hammer; M M Frank
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

4.  Complement fixation by the F(ab')2-fragment of pepsin-treated rabbit antibody.

Authors:  K B Reid
Journal:  Immunology       Date:  1971-05       Impact factor: 7.397

5.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

6.  Defective reticuloendothelial system function in rheumatoid arthritis.

Authors:  B D Williams; B A Pussell; C M Lockwood; C Cotton
Journal:  Lancet       Date:  1979-06-23       Impact factor: 79.321

7.  Studies on NEM-treated erythrocyte clearance in the rabbit, with special reference to the effects of circulating immune complexes.

Authors:  S Lawrence; C M Lockwood; D K Peters
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

8.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

9.  Binding of soluble immune complexes to human lymphoblastoid cells. II. Use of Raji cells to detect circulating immune complexes in animal and human sera.

Authors:  A N Theofilopoulos; C B Wilson; V A Bokisch; F J Dixon
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

  9 in total
  3 in total

1.  Demonstration of hepatic Fc receptor function in vivo.

Authors:  N Yousaf; J C Howard; B D Williams
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

2.  Studies in cobra venom factor treated rats of antibody coated erythrocyte clearance by the spleen: differential influence of red blood cell antigen number on the inhibitory effects of immune complexes on Fc dependent clearance.

Authors:  N Yousaf; J C Howard; B D Williams
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

3.  Systemic lupus erythematosus presenting as pneumococcal septicaemia and septic arthritis.

Authors:  J Webster; B D Williams; A P Smith; M Hall; J D Jessop
Journal:  Ann Rheum Dis       Date:  1990-03       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.